These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 7018522)

  • 1. [The additive effect of amantadine hydrochloride (Symmetrel) on parkinsonian patients receiving levodopa treatment (author's transl)].
    Shiozawa R; Kase M; Kuroiwa Y; Narabayashi H; Nishitani Y; Ohmoto T; Toyokura Y; Uono K
    No To Shinkei; 1981 Mar; 33(3):301-9. PubMed ID: 7018522
    [No Abstract]   [Full Text] [Related]  

  • 2. Amantadine and a fixed combination of levodopa and carbidopa in the treatment of Parkinson's disease.
    Savery F
    Dis Nerv Syst; 1977 Aug; 38(8):605-8. PubMed ID: 328244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Four-year treatment of patients with parkinsonism using amantadine alone or with levodopa.
    Timberlake WH; Vance MA
    Ann Neurol; 1978 Feb; 3(2):119-28. PubMed ID: 350129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amantadine and a fixed combination of carbidopa and levodopa in parkinsonism: a preliminary report.
    Savery F
    Curr Ther Res Clin Exp; 1976 Mar; 19(3):337-8. PubMed ID: 817863
    [No Abstract]   [Full Text] [Related]  

  • 5. [Psychological changes in parkinsonian patients during L-DOPA, amantidine, and L-DOPA + IDC treatment (author's transl)].
    Puca FM; Megna GF; Masi G; Specchio LM
    Riv Patol Nerv Ment; 1974 Oct; 95(5):676-84. PubMed ID: 4470268
    [No Abstract]   [Full Text] [Related]  

  • 6. Levodopa "drug holiday" with amantadine infusions as a treatment of complications in Parkinson's disease.
    Koziorowski D; Friedman A
    Mov Disord; 2007 May; 22(7):1033-6. PubMed ID: 17370308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Modification of Parkinson tremor by budipine. A comparative study with amantadine].
    Iizuka J; Fischer R
    Nervenarzt; 1986 Mar; 57(3):184-6. PubMed ID: 3515215
    [No Abstract]   [Full Text] [Related]  

  • 8. Visual hallucinations and delirium during treatment with amantadine (Symmetrel).
    Postma JU; Van Tilburg W
    J Am Geriatr Soc; 1975 May; 23(5):212-5. PubMed ID: 123540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effectiveness of amantadine (midantan) in the treatment of the parkinsonian syndrome].
    Kadykov AS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1976; 76(2):174-8. PubMed ID: 944514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and electromyographic examinations on the effect of hydrochloride (Viregyt-K) in the treatment of Parkinson's disease.
    Schubert U; Fischer GJ; Glass J
    Ther Hung; 1977; 25(2):55-63. PubMed ID: 898119
    [No Abstract]   [Full Text] [Related]  

  • 11. Amantadine HCL (Symmetrel) and its relation to Levo-Dopa in the treatment of Parkinson's disease.
    Schwab RS; England AC
    Trans Am Neurol Assoc; 1969; 94():85-90. PubMed ID: 4907453
    [No Abstract]   [Full Text] [Related]  

  • 12. The treatment with L-dopa and amantadine in Parkinson's disease.
    Pendefunda G; Pollingher B; Stefanache F; Gavril A; Oprisan C; Merling M; Nemteanu E; Ciunru M; Koropitzer I
    Ther Hung; 1975; 23(1):12-6. PubMed ID: 1105871
    [No Abstract]   [Full Text] [Related]  

  • 13. [Efficacy of amantadine sulfate as a infusion solution in the treatment of parkinsonian syndrome].
    Muschard F; Völler GW
    Med Welt; 1973 Feb; 24(5):183-4. PubMed ID: 4617092
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of Parkinson's Disease with levodopa and amantadine used as single drugs and in combined therapy.
    Callagham N; Mcllroy M; O'Connor M
    Ir J Med Sci; 1974 Mar; 143(2):67-78. PubMed ID: 4617744
    [No Abstract]   [Full Text] [Related]  

  • 15. The L-dopa sparing effect of G 31,406 in the treatment of parkinson's disease.
    Couto B; Oliveira C; Mattos JP; Freitas MR
    Neurol Neurocir Psiquiatr; 1976; 17(4):285-92. PubMed ID: 798128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Secondary effects of prolonged levodopa therapy in Parkinson's disease].
    Peiró Grasa A; Grau-Veciana JM
    Med Clin (Barc); 1985 Jun; 85(3):88-91. PubMed ID: 4021630
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term evaluation of amantadine and levodopa combination in parkinsonism by double-blind corssover analyses.
    Fahn S; Isgreen WP
    Neurology; 1975 Aug; 25(8):695-700. PubMed ID: 807869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of Dopaflex and Viregyt-K on gait and postural disturbances of operated and non-operated Parkinsonian patients.
    Boczán G; Borus F; Rózsa L
    Ther Hung; 1975; 23(1):17-20. PubMed ID: 1105872
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term therapy of Parkinson's disease with amantadine, alone and combined with levodopa.
    Zeldowicz LR; Hubermann J
    Can Med Assoc J; 1973 Oct; 109(7):588-93. PubMed ID: 4582563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A controlled study of the clinical effects of amantadine hydrochloride (Symmetrel).
    Merrick EM; Schmitt PP
    Curr Ther Res Clin Exp; 1973 Aug; 15(8):552-8. PubMed ID: 4200529
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.